Opportunities in the asthma market include the growth driven by innovative therapies like dexpramipexole and depemokimab, expanding patient pools due to rising asthma prevalence, and increased ...
The AI-powered Epidemiology Database is a comprehensive repository covering 500+ disease indications with 10-year epidemiology forecasts across the seven ...